
An exhilarating conversation with Azeem Azhar on medical A.I., science of aging, genome editing and the GLP-1 drugs
Ground Truths
00:00
GLP1 Agonists: Impact and Breakthroughs
This chapter explores the amazing technology of GLP1 agonists and their impact on our desire for food. It discusses how these drugs tackle our circuitry to make us feel full, decrease cravings, and potentially prevent Alzheimer's disease. The chapter also raises concerns about long-term treatment and the companies' interests in keeping people on the drugs.
Transcript
Play full episode